Ocumension Therapeutics
HKEX:1477

Watchlist Manager
Ocumension Therapeutics Logo
Ocumension Therapeutics
HKEX:1477
Watchlist
Price: 4.41 HKD 0.46% Market Closed
Market Cap: 3.6B HKD
Have any thoughts about
Ocumension Therapeutics?
Write Note

Intrinsic Value

The intrinsic value of one Ocumension Therapeutics stock under the Base Case scenario is 5.82 HKD. Compared to the current market price of 4.41 HKD, Ocumension Therapeutics is Undervalued by 24%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
5.82 HKD
Undervaluation 24%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Ocumension Therapeutics

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Ocumension Therapeutics
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Ocumension Therapeutics cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Ocumension Therapeutics?
Bearish
Neutral
Bullish

Fundamental Analysis

4.41 HKD
+0.46%
+0.46%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Ocumension Therapeutics
CN
Pharmaceuticals
Market Cap
3.6B HKD
IPO
Jul 10, 2020
Employees
187
China
Market Cap
3.6B HKD
Industry
Pharmaceuticals
IPO
Jul 10, 2020
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Ocumension Therapeutics

Provide an overview of the primary business activities
of Ocumension Therapeutics.

What unique competitive advantages
does Ocumension Therapeutics hold over its rivals?

What risks and challenges
does Ocumension Therapeutics face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Ocumension Therapeutics.

Provide P/S
for Ocumension Therapeutics.

Provide P/E
for Ocumension Therapeutics.

Provide P/OCF
for Ocumension Therapeutics.

Provide P/FCFE
for Ocumension Therapeutics.

Provide P/B
for Ocumension Therapeutics.

Provide EV/S
for Ocumension Therapeutics.

Provide EV/GP
for Ocumension Therapeutics.

Provide EV/EBITDA
for Ocumension Therapeutics.

Provide EV/EBIT
for Ocumension Therapeutics.

Provide EV/OCF
for Ocumension Therapeutics.

Provide EV/FCFF
for Ocumension Therapeutics.

Provide EV/IC
for Ocumension Therapeutics.

Show me price targets
for Ocumension Therapeutics made by professional analysts.

What are the Revenue projections
for Ocumension Therapeutics?

How accurate were the past Revenue estimates
for Ocumension Therapeutics?

What are the Net Income projections
for Ocumension Therapeutics?

How accurate were the past Net Income estimates
for Ocumension Therapeutics?

What are the EPS projections
for Ocumension Therapeutics?

How accurate were the past EPS estimates
for Ocumension Therapeutics?

What are the EBIT projections
for Ocumension Therapeutics?

How accurate were the past EBIT estimates
for Ocumension Therapeutics?

Compare the revenue forecasts
for Ocumension Therapeutics with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Ocumension Therapeutics and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Ocumension Therapeutics against its competitors.

Analyze the profit margins
(gross, operating, and net) of Ocumension Therapeutics compared to its peers.

Compare the P/E ratios
of Ocumension Therapeutics against its peers.

Discuss the investment returns and shareholder value creation
comparing Ocumension Therapeutics with its peers.

Analyze the financial leverage
of Ocumension Therapeutics compared to its main competitors.

Show all profitability ratios
for Ocumension Therapeutics.

Provide ROE
for Ocumension Therapeutics.

Provide ROA
for Ocumension Therapeutics.

Provide ROIC
for Ocumension Therapeutics.

Provide ROCE
for Ocumension Therapeutics.

Provide Gross Margin
for Ocumension Therapeutics.

Provide Operating Margin
for Ocumension Therapeutics.

Provide Net Margin
for Ocumension Therapeutics.

Provide FCF Margin
for Ocumension Therapeutics.

Show all solvency ratios
for Ocumension Therapeutics.

Provide D/E Ratio
for Ocumension Therapeutics.

Provide D/A Ratio
for Ocumension Therapeutics.

Provide Interest Coverage Ratio
for Ocumension Therapeutics.

Provide Altman Z-Score Ratio
for Ocumension Therapeutics.

Provide Quick Ratio
for Ocumension Therapeutics.

Provide Current Ratio
for Ocumension Therapeutics.

Provide Cash Ratio
for Ocumension Therapeutics.

What is the historical Revenue growth
over the last 5 years for Ocumension Therapeutics?

What is the historical Net Income growth
over the last 5 years for Ocumension Therapeutics?

What is the current Free Cash Flow
of Ocumension Therapeutics?

Discuss the annual earnings per share (EPS)
trend over the past five years for Ocumension Therapeutics.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Ocumension Therapeutics

Balance Sheet Decomposition
Ocumension Therapeutics

Current Assets 1.2B
Cash & Short-Term Investments 1.6B
Receivables 151.4m
Other Current Assets -597.8m
Non-Current Assets 1.8B
Long-Term Investments 56.7m
PP&E 471m
Intangibles 1.2B
Other Non-Current Assets 95.5m
Current Liabilities 224.9m
Accounts Payable 271.1m
Accrued Liabilities 18.2m
Other Current Liabilities -64.3m
Non-Current Liabilities 32.7m
Long-Term Debt 2.7m
Other Non-Current Liabilities 30.1m
Efficiency

Earnings Waterfall
Ocumension Therapeutics

Revenue
310.3m CNY
Cost of Revenue
-129.4m CNY
Gross Profit
180.9m CNY
Operating Expenses
-525.7m CNY
Operating Income
-344.9m CNY
Other Expenses
22.2m CNY
Net Income
-322.7m CNY

Free Cash Flow Analysis
Ocumension Therapeutics

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Ocumension Therapeutics's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Negative ROE
31/100
Profitability
Score

Ocumension Therapeutics's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Ocumension Therapeutics's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Ocumension Therapeutics's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Ocumension Therapeutics

Wall Street analysts forecast Ocumension Therapeutics stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Ocumension Therapeutics is 10.12 HKD with a low forecast of 8.94 HKD and a high forecast of 12.52 HKD.

Lowest
Price Target
8.94 HKD
103% Upside
Average
Price Target
10.12 HKD
130% Upside
Highest
Price Target
12.52 HKD
184% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Ocumension Therapeutics?

Click here to dive deeper.

Dividends

Ocumension Therapeutics
does not pay dividends
Shareholder Yield

Current shareholder yield for Ocumension Therapeutics is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one Ocumension Therapeutics stock?

The intrinsic value of one Ocumension Therapeutics stock under the Base Case scenario is 5.82 HKD.

Is Ocumension Therapeutics stock undervalued or overvalued?

Compared to the current market price of 4.41 HKD, Ocumension Therapeutics is Undervalued by 24%.

Back to Top